
Sign up to save your podcasts
Or
Of all the things women worry about when it comes to hormone therapy, breast cancer, for many, tops the list. Our current understanding of breast cancer risk–even among at-risk women–has changed dramatically in recent years and continues to evolve. To fully understand hormone therapy and breast cancer risk, we need to understand that hormone therapy is not all the same, nor is breast cancer. There are many forms and formulations of hormone therapy and there are many variations of the disease we call breast cancer. This week we break it all down with the Director of the Gynecology Center for Cancer Survivors and At-Risk Women at UCSF, Dr. Mindy Goldman, who wants all women to know, no matter their situation, they do not have to suffer with menopausal symptoms.
Mindy Goldman, MD, is Chief Clinical Officer & Clinical Professor Emeritus at UCSF. For almost three decades, Dr. Goldman has been a Clinical Professor in the Department of OB/GYN at UCSF, where she is also the Director of the Gynecology Center for Cancer Survivors and At-Risk Women. In addition to her role as Midi’s Chief Clinical Officer, she is a nationally recognized expert in the management of women’s health issues, including menopause, for women with cancer or at high risk. She has helped author guidelines in these areas for the American College of Obstetrics and Gynecology (ACOG). She is on the survivorship panel for the National Comprehensive Cancer Network (NCCN) where she is the Chair of the menopause panel and the Co-Chair of the sexual functioning panel, which provide guidelines in these topic areas for practicing oncologists. Throughout her career, Dr. Goldman has received numerous recognitions, including: San Francisco Magazine: Top Doctors (2015-2022), America's Top Doctors for Cancer (7th-10th Edition) and Exceptional Women In Medicine (2019-2021). You can learn more about her and her work at Dr. Mindy Goldman.
Subscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page
Follow Us on Instagram:
Feisty Menopause: @feistymenopause
Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099
Support our Partners:
Hettas: Use code FEISTY20 for 20% off at https://hettas.com/
Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/
Nutrisense: Go to nutrisense.io/hitplay and use code: HITPLAY to get $125 off
Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/
Paradis Sport: Use code: FEISTY20 for 20% off any single item at https://paradissport.com/
4.9
655655 ratings
Of all the things women worry about when it comes to hormone therapy, breast cancer, for many, tops the list. Our current understanding of breast cancer risk–even among at-risk women–has changed dramatically in recent years and continues to evolve. To fully understand hormone therapy and breast cancer risk, we need to understand that hormone therapy is not all the same, nor is breast cancer. There are many forms and formulations of hormone therapy and there are many variations of the disease we call breast cancer. This week we break it all down with the Director of the Gynecology Center for Cancer Survivors and At-Risk Women at UCSF, Dr. Mindy Goldman, who wants all women to know, no matter their situation, they do not have to suffer with menopausal symptoms.
Mindy Goldman, MD, is Chief Clinical Officer & Clinical Professor Emeritus at UCSF. For almost three decades, Dr. Goldman has been a Clinical Professor in the Department of OB/GYN at UCSF, where she is also the Director of the Gynecology Center for Cancer Survivors and At-Risk Women. In addition to her role as Midi’s Chief Clinical Officer, she is a nationally recognized expert in the management of women’s health issues, including menopause, for women with cancer or at high risk. She has helped author guidelines in these areas for the American College of Obstetrics and Gynecology (ACOG). She is on the survivorship panel for the National Comprehensive Cancer Network (NCCN) where she is the Chair of the menopause panel and the Co-Chair of the sexual functioning panel, which provide guidelines in these topic areas for practicing oncologists. Throughout her career, Dr. Goldman has received numerous recognitions, including: San Francisco Magazine: Top Doctors (2015-2022), America's Top Doctors for Cancer (7th-10th Edition) and Exceptional Women In Medicine (2019-2021). You can learn more about her and her work at Dr. Mindy Goldman.
Subscribe to the Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-page
Follow Us on Instagram:
Feisty Menopause: @feistymenopause
Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099
Support our Partners:
Hettas: Use code FEISTY20 for 20% off at https://hettas.com/
Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/
Nutrisense: Go to nutrisense.io/hitplay and use code: HITPLAY to get $125 off
Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/
Paradis Sport: Use code: FEISTY20 for 20% off any single item at https://paradissport.com/
1,319 Listeners
1,087 Listeners
114 Listeners
111 Listeners
189 Listeners
69 Listeners
307 Listeners
2,561 Listeners
7,776 Listeners
198 Listeners
1,172 Listeners
577 Listeners
888 Listeners
73 Listeners
19 Listeners
27 Listeners
333 Listeners
1,102 Listeners
5 Listeners
47 Listeners
1 Listeners
48 Listeners